The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2014
At a glance
- Drugs Testosterone (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- Acronyms VITA-HF
- 10 Jun 2017 Biomarkers information updated
- 23 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 20 Aug 2012 Additional lead trial investigators added as reported by ClinicalTrials.gov record.